Hospitals in Greece will start administering monoclonic antibodies to Covid-19 patients with top priority to high-risk Covid-19 patients who belong to vulnerable groups, the Health Ministry announced on Thursday. the country has so far received 2,000 doses of monoclonic antibodies.
According to Deputy Health Minister Mina Gaga, the administration will take place in hospitals with the biggest experience.
Priority patients reportedly are:
- immune-compromised
- those who have recieved transplant
- patients with neoplasm
- pregnant women in the last 3 months
Patients must be aged 12 or over, and they must have been confirmed coronavirus-positive with a PCR test over the last 5 days.
Monoclonal antibodies are administered in a single dose, but require a hospital setting, as they are administered intravenously and require 1-hour medical monitoring for possible allergic reactions.
A single dose of Regen-COV treatment prevents 81.6% of infections for at least eight months, the American biotechnology company announced on Monday.
This means that synthetic antibodies could offer lasting protection in immune-compromised patients who do not respond to vaccination.
Therapy is prescribed by doctors who also initiate the application process.
The monoclonic antibodies therapy will be administered in the following ten public hospitals:
- Athens: Sotiria, Sismanoglio
- Thessaloniki: AHEPA, Papageorgiou
- General hospitals in: Alexandroupoli, Heraklio, Ioannina, Larissa, Lamia, Patras/Rio
